Zyprexa Intramuscular recalls
The FDA has published 1 recall involving Zyprexa Intramuscular since 2021. The latest was reported on 18 Aug 2021. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 18 Aug 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why zyprexa intramuscular is recalled
Companies
By year
All zyprexa intramuscular recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Zyprexa Intramuscular, Olanzapine for Injection recalled by Eli Lilly & | Eli Lilly | Manufacturing (CGMP) Deviations | IN, MS, OH |
Should you stop taking Zyprexa Intramuscular?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.